Abstract
C c o i M olorectal cancer (CRC) remains a major clinical and public health challenge, with 148,810 new cases and 9,960 deaths expected in the United States in 2008.1 The eld of CRC research is dynamic and expanding in several irections, encompassing areas of clinical and outcomes esearch, epidemiology, public health, and molecular scinces. In this review, we summarize important developents in CRC screening and surveillance over the past everal years and discuss the present state of the art of his field.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
